Transkaryotic Therapies Incorporated RKT

Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies. TKT develops, and intends to commercialize, protein products for rare and common diseases. Through its three development platforms Niche Protein® products, Gene-Activated® proteins, and Gene Therapy, TKT currently has products in clinical development for the treatment of Fabry disease, anemia, Hunter syndrome, hemophilia A. The breadth of TKT's pipeline is a result of the company's strong scientific base, which integrates cellular and molecular biology and protein chemistry to develop biologics.

Contact Details: 195 Albany Street Cambridge MA 02139 United States of America Tel: 617 349 0200 Fax: 617 491 7903 Email: info@tktx.com WWW: www.tktx.com/

Loading...

Transkaryotic Therapies Incorporated RKT (TKTX) Financial information Links from Barchart
TKTX Quote from from Barchart.com
TKTX Chart from from Barchart.com
TKTX Profile from from Barchart.com
TKTX Opinion from from Barchart.com
→View more Transkaryotic Therapies Incorporated RKT finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 141 times since April 2007, the link to the organisation's website has been followed 39 times

Recent Search Terms used to find this page: TRANSKARYOTIC QUOTE | TRANSKARYOTIC QUOTE | transkaryotic therapies | Transkaryotic Therapies | .

Search for more companies in Cambridge

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Transkaryotic Therapies Incorporated RKT